Abstract| Volume 177, ISSUE 1, P27, August 2013

Randomized Trial of Rifampicin in MSA: Primary Outcomes and Effect on Autonomic Function

      Objective: To determine the effect of rifampicin on clinical progression and progression of autonomic failure in multiple system atrophy (MSA).
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Autonomic Neuroscience: Basic and Clinical
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect